Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Ann Rheum Dis. 2020 Dec;79(12):1665-1666. doi: 10.1136/annrheumdis-2020-217255. Epub 2020 Jun 26.
No abstract available

Keywords: DMARDs (synthetic); rheumatoid arthritis; vaccination.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunocompromised Host*
  • Male
  • Middle Aged
  • Pneumococcal Vaccines / administration & dosage*
  • Pneumonia / immunology
  • Pneumonia / prevention & control
  • Vaccination / statistics & numerical data*

Substances

  • Antirheumatic Agents
  • Pneumococcal Vaccines